Table of Contents
- Why Upskilling Is the Lever Most Programs Underuse
- Audience Segmentation: Five Distinct Populations
- Role-Based Curriculum Design
- Delivery Models That Work
- Measuring Capability, Not Completion
- Scaling Without Diluting
- Sustaining Capability Over Time
- Common Failure Modes and How to Avoid Them
- References
Executive Summary
Upskilling the life sciences workforce for AI is consistently the most under-resourced lever in pharma AI strategies. The default approach — a one-hour AI literacy course pushed to the entire organization — produces completion certificates and very little capability. Real upskilling for AI in pharma requires audience segmentation, role-based curricula, sustained delivery, and rigorous measurement of capability rather than activity. Done well, it produces durable competitive advantage; done poorly, it produces compliance theatre.
This article lays out a practical approach to AI upskilling for life sciences: who the distinct audiences are, what each needs, how to deliver it without overwhelming the operating organization, and how to measure that the investment is actually producing capability. We close with the failure modes that derail upskilling programs and how to recognize them early enough to correct.
Why Upskilling Is the Lever Most Programs Underuse
Pharma AI strategies typically allocate substantial budget to platforms, models, and infrastructure — and a residual line item to “training” that gets fulfilled by a vendor-provided one-hour module. The mismatch between investment levels is striking when you put it next to the leverage each lever actually has on outcomes. Platforms enable capability; capability requires people who can use the platforms well. The constraint on AI value capture is more often capability than capacity, but the budget allocation rarely reflects this.
The under-investment has predictable causes. Training is hard to scope because the right answer depends on roles and use cases that haven’t all been defined yet. Training outcomes are hard to measure in the short term, while platform deployment outcomes are visible and tangible. Training requires sustained attention from senior people whose time is contested. And training has historically been a cost center rather than a strategic capability, with reflexes and processes shaped by that history.
Organizations that have actually built AI capability — across industries and including the small but growing set of pharma organizations doing it well — have made workforce upskilling a first-class strategic investment. They’ve put capable senior leaders in charge of it. They’ve built dedicated learning teams with real subject matter expertise. They’ve measured capability development as rigorously as platform deployment. And they’ve seen returns that are hard to ignore: 3-5x productivity multipliers on AI programs, faster time-to-value, higher adoption, and durable competitive advantage in talent attraction and retention.
Audience Segmentation: Five Distinct Populations
The single most common upskilling failure is treating the workforce as a single audience. Different populations need fundamentally different content, depth, and delivery. The five distinct populations that almost every life sciences organization has to address.
| Population | What They Need | Typical Failure Mode |
|---|---|---|
| Executive leadership | Strategic literacy, investment frameworks, risk awareness | Content too technical or too generic to inform real decisions |
| Functional leaders | Use case identification, change management, vendor evaluation | Treated as either executives or end users; neither fits |
| End users | Workflow-specific training, judgment for AI-augmented work | Generic AI literacy substituted for role-based training |
| Technical practitioners | Deep technical content on models, MLOps, validation | Vendor courses substituted for organization-specific context |
| Quality and regulatory | AI-specific risk frameworks, validation methodology, audit posture | Treated as end users rather than as governance experts |
Each population needs not only different content but different delivery and different relationships with the program. Executive leadership needs concise strategic briefings; technical practitioners need sustained deep curricula; quality and regulatory need specialized content tailored to their formal accountabilities. Programs that fail to segment end up either over-investing in one population at the expense of others or providing generic content that doesn’t really fit anyone.
The functional leader population is the most underserved
Of the five populations, functional leaders — directors, senior managers, and group leads in clinical, manufacturing, regulatory, and commercial functions — are typically the most underserved by upskilling programs. They’re treated as executives in some content and as end users in others, and neither fits their actual role. Functional leaders are the people who identify use cases, sponsor projects within their function, manage the change inside their teams, and accept or reject AI-augmented workflows. Investing in their capability has unusually high leverage because they multiply the program’s effect across their organizations.
Role-Based Curriculum Design
Effective upskilling curricula are designed around the actual work each role does, not around a generic AI taxonomy. The design process starts with a clear understanding of the role’s current and target state, identifies the AI-specific knowledge and judgment required for the target state, and builds a progression that develops both the underlying concepts and the practical fluency needed to apply them.
For a clinical writer, for example, the curriculum might cover: how large language models work at a level useful for understanding their failure modes; how to use AI assistance for drafting while retaining medical writing judgment; how to detect and correct AI-generated errors; how to document AI use in ways that satisfy audit requirements; how to escalate situations where AI output cannot be safely used. The curriculum is concrete, role-specific, and tied to the actual work products the writer is responsible for.
For a QA reviewer, the same underlying technology is presented through a different lens: how to evaluate AI-generated outputs against quality criteria; how to assess validation evidence for AI systems; how to recognize patterns of AI-specific risk; how to document review decisions in ways that hold up under inspection. Same technology, very different curriculum.
Delivery Models That Work
Curriculum design is necessary but not sufficient. The delivery model determines whether the curriculum actually produces capability. The delivery models that consistently work in pharma share several properties.
They blend modalities. Self-paced content for foundational concepts, instructor-led sessions for discussion and application, hands-on labs for practical skill development, and on-the-job application with coaching for sustained capability building. Each modality addresses a different aspect of capability development, and programs that rely on a single modality consistently underperform.
They are workplace-integrated. Training that happens entirely outside the work context tends to evaporate when learners return to their work. Training that integrates with real work — through projects, applied assignments, and coached practice — sticks much better. The integration costs more in coordination but produces dramatically better capability outcomes.
They include cohorts. Learning is social. Cohorts that progress together build peer support, share insights across functions, and create a community that sustains the learning beyond the formal program. Cohort design also creates an organizational network of capable people who can collaborate on AI initiatives going forward.
They include coaches. Self-directed learning works for some content for some learners, but most adult learners benefit from coaching that helps them apply concepts to their specific situation. Coaches don’t have to be deep technical experts; they have to be skilled at helping learners reflect on their work and develop their judgment.
Measuring Capability, Not Completion
Most upskilling programs measure activity — courses completed, hours spent, certifications earned. Activity measurement is necessary for compliance reporting but is a poor proxy for capability. Programs that confuse the two routinely report excellent training metrics while delivering very little real capability.
Capability measurement is harder but pays back. The components of a capability measurement system include the following.
- Pre and post assessments. Designed against role-specific learning objectives, with scenarios that resemble real work rather than knowledge-recall questions.
- Manager observations. Structured ratings from managers on whether the trained person now does the work differently and better.
- Peer feedback. Cohort-based peer feedback, particularly valuable for soft-skill aspects of AI capability like judgment and communication.
- Work product assessment. Sampling of actual work products produced by trained personnel against quality and AI-use criteria.
- Sustained application. Tracking, several months after training, whether the trained capabilities are being used in regular work.
- Business outcomes. Connection back to the use case business cases — are the projected productivity, quality, or capacity outcomes showing up in the work of trained personnel?
The measurement system should be light enough to be sustainable but rigorous enough to surface real issues. Programs that build elaborate measurement frameworks they can’t sustain end up with no measurement at all; programs that build measurement that’s too superficial miss the issues that matter. The right balance is specific to the organization’s context but tends toward simpler, sustained measurement over elaborate but infrequent assessment.
Scaling Without Diluting
Upskilling programs face a tension between depth and reach. Deep programs serve a small population well; broad programs reach many but often deliver less per learner. Scaling without diluting requires structural choices that allow both, addressed through different program tracks rather than a single one-size-fits-all approach.
The structure that works for most life sciences organizations involves three tracks. A breadth track provides foundational AI literacy to the broad workforce, with a focus on practical safe use of widely available AI tools and recognition of when to involve specialists. A depth track develops technical and functional specialists with deep capability in specific AI domains. A leadership track builds the strategic and managerial capabilities that enable senior people to lead AI-augmented organizations effectively.
Each track has its own design, delivery, and measurement model. Resources allocated across the tracks reflect the strategic priorities of the program and the demographic distribution of the workforce. The breadth track typically reaches the most people but absorbs the smallest per-capita investment; the depth track absorbs the most per-capita investment but reaches the fewest people. The right balance shifts as the program matures — early investment is often heavier on the depth track to build the internal capability needed to lead the broader effort.
Sustaining Capability Over Time
Upskilling is not a project. The pace of AI capability evolution means that capability built today will partly atrophy and partly become obsolete within eighteen months. Sustained capability requires sustained investment, continuous curriculum refresh, and a culture of ongoing learning that goes beyond formal programs.
Sustaining practices that pay back include the following. An internal AI community of practice that connects practitioners across functions, shares learnings, and provides peer support. Regular curriculum refresh cycles tied to the evolution of the technology and the organization’s use cases. Recognition systems that reward capability development and visible application — not just project completion. Career pathways that legitimize AI capability as a path to advancement and status rather than as an extracurricular activity. And organizational rhythms — town halls, hackathons, retrospectives — that maintain the cultural energy around AI capability building.
Common Failure Modes and How to Avoid Them
Several failure modes are common enough to be worth naming explicitly. Recognizing them early is the difference between a program that corrects course and one that quietly degrades into compliance theatre.
Vendor-led curriculum substitution. Allowing a vendor’s training material to substitute for organization-specific curriculum is the single most common failure. Vendor material is generic by necessity; your workforce needs content tied to your data, your workflows, your governance, and your use cases.
Completion-as-success. Reporting completion percentages as if they were capability development. Completion is necessary; it is not sufficient. Programs that don’t measure beyond completion don’t know whether they’re producing capability.
Single-modality delivery. Relying on self-paced e-learning alone, or on instructor-led sessions alone, produces consistently inferior outcomes to blended delivery.
Under-investment in functional leaders. Skipping or shortchanging the functional leader population leaves the highest-leverage population underserved and weakens the multiplier effect across their organizations.
One-time program design. Treating upskilling as a project with a beginning, middle, and end rather than as an ongoing capability that needs continuous investment.
Programs that recognize these failure modes early and design around them have a substantially higher likelihood of producing real capability. The investment is significant but the return is durable competitive advantage in a domain where competitive advantage compounds over time.
The “build, buy, or partner” decision for upskilling capability
An underdiscussed dimension of upskilling strategy is how the organization sources the capability to deliver the program. Three options exist, and each has different cost and capability implications. Building internally — through a dedicated learning team with subject matter expertise — produces the deepest organization-specific content but requires substantial upfront investment and time to build credibility. Buying — through external training vendors and content providers — produces faster initial deployment but content that lacks organization-specific depth and runs the risk of vendor-led curriculum substitution. Partnering — through structured relationships with academic institutions, industry consortia, or specialized training firms — combines elements of both and can produce content that is both deep and current with industry developments.
The right answer is typically a portfolio across all three. Foundational AI literacy can often be sourced from external content with light internal customization. Role-specific curriculum requires internal investment to capture the workflow context that vendors don’t have access to. Specialized technical content benefits from partnerships with universities and research institutions that have deeper expertise than most pharma organizations can build internally. The portfolio composition shifts as the program matures — early stages typically lean more on external sources while internal capability is being built; mature stages shift the balance toward internal content as the in-house team develops.
Coordinating with broader organizational learning investments
AI upskilling rarely sits alone in the organization’s learning portfolio. Leadership development, technical training, regulatory training, compliance training, and other programs all compete for the workforce’s time and attention. Coordinating with these programs — rather than running AI upskilling as a parallel and competing initiative — produces materially better outcomes than either ignoring the broader landscape or trying to subsume AI training into existing programs.
The coordination practices that work include the following. Joint planning between the AI upskilling owner and the broader learning leadership, with explicit attention to the workforce’s total learning load. Shared infrastructure where it makes sense — learning management systems, content authoring platforms, evaluation tooling — that avoids duplication and provides consistent learner experience. Coordinated communications and branding so that the workforce sees a coherent learning offer rather than a fragmented set of competing programs. And shared measurement frameworks that allow the organization to evaluate the total learning portfolio rather than each program in isolation.
Special considerations for AI upskilling in regulated functions
Upskilling for AI in regulated functions — quality, regulatory affairs, pharmacovigilance, validation — requires specialized treatment that generic AI training programs typically don’t provide. The professionals in these functions need to understand AI well enough to evaluate vendor claims, validate AI systems, identify AI-specific risks, and document AI-related decisions in ways that hold up to inspection. Generic AI literacy doesn’t develop these capabilities; specialized curriculum tailored to each regulated function does.
The specialized curriculum addresses several themes. Foundations of how AI systems work, with depth appropriate to the function — quality reviewers need different depth than regulatory writers. AI-specific risk frameworks that map onto the existing risk frameworks the function uses for non-AI systems. Validation methodology for AI systems, including the heterogeneity of approaches that have emerged across the industry and the regulator-published guidance available. Documentation standards for AI use that satisfy current and emerging inspection expectations. And case studies of AI in regulated work — what has worked, what has failed, what the lessons are. The investment in specialized curriculum for regulated functions has unusually high leverage because these functions become bottlenecks for AI deployment if their capability lags the deployment pace.
Measuring upskilling against business outcomes
The most rigorous form of upskilling measurement connects training investment to business outcomes — productivity, quality, capacity, or financial measures that tie back to the use case business cases. The connection is methodologically challenging because many factors influence business outcomes beyond training, but several techniques produce useful directional signal even with the methodological challenge.
The techniques that work include matched-pair comparisons of trained versus untrained populations performing similar work, with attention to confounding factors. Time-series analysis of business metrics for populations that completed training versus the period before training. Manager-reported productivity changes attributed to training, calibrated against quantitative measures where possible. And learner self-reports of how training has changed their work, validated against work product samples and manager observations. The measurement is imperfect but produces signal that is materially more useful than activity measurement alone — and the discipline of attempting business-outcome measurement tends to improve the design of the training itself, because designers have to think about what behaviors they’re trying to produce and how to know whether they’re producing them.
References
For Further Reading
- Master Data Management for Life Sciences and Pharmaceuticals Industries — CluedIn.
- AI in Pharma and Life Sciences — Deloitte.
- Scaling up AI across the life sciences value chain — Deloitte Insights.
- 2025 Life Sciences Outlook — Deloitte Insights.
- How pharma is rewriting the AI playbook — McKinsey & Company.
- Generative AI to Reshape the Future of Life Sciences — Deloitte.








Your perspective matters—join the conversation.